The future of digital health part 2: Digital patient engagement and virtual healthcare delivery

Part 2

Last week, we started a new series featuring healthcare visionary and thought leader Andy Dé. In this series, Dé discusses how COVID-19 has triggered remarkable digital transformation and uncovers five long-term innovation implications that providers, healthcare leaders, and payers need to consider.

Catch up on the first implication—advanced analytics for vaccine administration—then read on to explore number two in this week’s article.


Innovation implication #2: Digital patient engagement and virtual healthcare delivery

Protecting the health, well-being and safety of healthcare practitioners and first responders is paramount — and will accelerate adoption of Digital Patient Engagement (DPE), enabled by Virtual Healthcare Delivery (VHD) solutions (also known as “Hospital at Home.)”

As pictured below, there are three primary drivers for DPE and VHD:

  1. A clear need to deliver high quality healthcare to a massive number of patients afflicted with a contagious disease and co-morbidities.
  2. Risks presented by acquiring COVID-19 combined with continued lack of sufficient equipment, PPE, and rest for healthcare workers
  3. The need to minimize direct contact of providers with patients while increasing level of care efficiency and productivity

When I have this conversation with healthcare colleagues, the next question I typically receive is: “Andy, this sounds great, but where do we start?” The chart below demonstrates several helpful examples of how technology can be used to transform typical patient interactions and needs:

If you’re interested in more details about how to actually make changes like the ones described above, reach out to start a conversation. Join me back here on the MedeAnalytics blog next week for Innovation implications #3: Artificial intelligence and machine learning for operations, revenue cycle and supply change management innovation and #4: Medical robotics.

Andy Dé

Andy Dé is the Chief Marketing Officer. Andy joined MedeAnalytics in March 2021 bringing more than 20 years of enterprise software product marketing, product management and industry strategy experience. In his role, Andy oversees the company’s go-to-market (GTM) strategy and marketing. He is passionate about healthcare innovation and is recognized as an industry thought leader in healthcare.

Get our take on industry trends

The missing piece to your Population Health strategy:

The missing piece to your Population Health strategy: A prescription for maximizing pharmacy data 

October 20, 2022

The healthcare industry is swimming in data; sometimes organizations can even feel like they are drowning in available information. To…

Read on...
Dr. Lyle Berkowitz

Data, analytics and AI-enabled healthcare: Four key takeaways from the IS22 keynote

October 18, 2022

The 2022 Impact Summit (IS22) was outstanding for a plethora of reasons—and Dr. Lyle Berkowitz is foremost among them. For this year’s keynote, Lyle…

Read on...
revenue management

Three need-to-know trends in revenue cycle management

August 17, 2022

One of our favorite things about being back in-person is connecting with clients and colleagues at industry events! At the…

Read on...
schweppe-healthscene

The role of analytics in whole person care: 4 key takeaways

July 28, 2022

David Schweppe, Chief Analytics Officer at MedeAnalytics (right), being interviewed by John Lynn, Founder and Chief Editor at Healthcare IT…

Read on...